Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. - Wikidata - wikimedia - TriplyDB

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

http://www.wikidata.org/entity/Q42255433

about

Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies Defining HIV-1 transmission clusters based on sequence data.Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations.Next-generation sequencing of HIV-1 RNA genomes: determination of error rates and minimizing artificial recombination Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013 Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013.Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.Epitope-specific CD8+ T cell kinetics rather than viral variability determine the timing of immune escape in simian immunodeficiency virus infection.Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012.Diminished transmission of drug resistant HIV-1 variants with reduced replication capacity in a human transmission model.HIV reverse-transcriptase drug resistance mutations during early infection reveal greater transmission diversity than in envelope sequences.Lower pre-ART intra-participant HIV-1 pol diversity may not be associated with virologic failure in adults.Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort.

P2860

Q28544845-DF2150A9-BA49-46FA-99C2-07C63E863F06 Q28547790-FCA7D1CB-527A-49B1-B56A-D199955D85CB Q28547874-F8B577E6-3724-43E2-92D6-ABF52D7B6F69 Q28554999-6D115844-8ACE-45EB-96FC-43A73DA8C553 Q33829130-2A154357-5DDA-4622-9CB2-5E1231138B2D Q34044256-743A40F3-5ACA-4CFC-A7DE-61B61814B35F Q34994579-53CB7064-20D1-4006-A37F-7750DAB997AB Q35032733-F443BFAB-8A43-494D-8DE8-07B74F1A9F4C Q35056873-EB6AB479-C5B3-4CC6-960D-118754C24AC6 Q36438778-459EDC9F-0A21-4CFD-A724-BAF94CC1A927 Q38644734-353408BE-A7F3-4671-BB1A-615572F4B7AC Q39289633-1DA3A28B-A985-4D5E-AEF6-185A4C1501B2 Q39485008-76283BB0-810E-45F8-96B8-E3523E8956A1 Q40223002-D7B7D9D5-1D03-43F0-8815-C4A26802DD7F Q41368316-05D8B360-216F-494C-A0B8-435C39B4F2AF Q41551955-9EE18604-2303-4E46-9945-79C39BABF6D3 Q41603336-FF0FD0F2-6728-44C7-99ED-B5455E55CD83 Q42212831-7E984312-7B3D-44CC-9C4B-E87DF96A5A8F Q48165950-EE339FB5-2B35-415E-8623-815DC119BB3D Q54247474-81B8D9AF-7300-4375-9A47-2C1EB278517D

P2860

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

http://www.wikidata.org/entity/Q42255433

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

@en

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

@nl

type

label

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

@en

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

@nl

prefLabel

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

@en

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

@nl

P1433

Q42255433-2DD80D41-0689-4C42-A75C-79ACF21398FD

P1476

Q42255433-A4C1C6C4-1C33-4CAC-A157-0AE62041BED5

P2093

Q42255433-183C48F1-B394-4035-98E0-C5C3EFB73FB2

Q42255433-2554B320-26B1-42D5-A348-A9DED99BCB9B

Q42255433-2E5BACFC-11A7-49AF-88DF-E71B0C37D5C2

Q42255433-30F0ACA1-209C-4E87-AAC0-55E4513E4A13

Q42255433-593B5170-7DD4-4FCE-8051-D33D2C300ADB

Q42255433-A0262912-C607-40B4-84D8-F8DB1376B566

Q42255433-ABCDAD10-8D6D-4206-A62D-F043C7CDF9C2

Q42255433-D38E00DC-670F-4ED8-9662-12F7BB7A968F

Q42255433-DF783C79-A5CF-46B2-BACF-07125C4DD813

Q42255433-E733F8E3-D9EB-42E2-B1DD-E09F485F2D71

P2860

Q42255433-19E4D04B-BDE4-4E45-9846-8E59496BA8B5

Q42255433-1A3CC8DB-0BE8-40F3-979A-C27EBE8A1B0F

Q42255433-2C5B7B66-357C-4ADE-94C6-06C8CABEB0DC

Q42255433-35AD6451-8246-4474-963B-8F85591C606F

Q42255433-394CAEDA-7548-4B6E-9C55-A19D1029E0C4

Q42255433-45F685F5-93A4-4108-A401-419A9E88454F

Q42255433-5DD04E24-55EF-4E1F-BDAF-AA1BA379EF93

Q42255433-61564AC0-85B8-4AC5-8404-683CA9D86CDA

Q42255433-67493888-B2D8-405D-B4A1-85DFCB93A8A5

Q42255433-767FB103-CEBC-4D6C-B5C1-9A2A541748C5

P304

Q42255433-877B7751-46FB-4151-B7D3-A846D9FE473F

P31

Q42255433-B2612269-110C-4382-81BF-D667D9BE6717

P356

Q42255433-F628A5A8-5502-469D-8718-1F2485FC6189

P407

Q42255433-110B7236-EF5C-4FAB-8400-4CF4489436C6

P433

Q42255433-B6ABB714-BC69-4090-8055-7B8F60D7B538

P478

Q42255433-51D988C8-9541-4A02-9A07-6DC12338578C

P50

Q42255433-08A53B37-1E5B-4B22-9E1A-2929E4EDAF00

Q42255433-1ED8A5D7-1DFB-4FC7-AB7B-D6F6B2D557A0

Q42255433-3918A613-D173-41D9-A6C7-6A91265F8B6B

Q42255433-4532BFC8-9219-48B0-B1E4-B9F03866425C

Q42255433-680B8D06-0EFD-4189-8D5E-84F15E045030

Q42255433-6FFD9BD9-15E2-4B8E-A312-9820ADC4E00C

Q42255433-8B67DD71-D70B-4D86-B1C7-CE5B36FFE74E

Q42255433-A458CA6D-02B1-4009-B9EC-111605145125

Q42255433-A7EAA481-CAD6-48A6-8174-C4E5FEA5ABA7

Q42255433-C714BD00-3E74-48FD-B9CE-EBDA1CE3F929

P577

Q42255433-0FC5BAEC-6051-43DD-B5FD-2CED8B6892D3

P5875

Q42255433-4E17C5AD-5235-409D-A2AF-AF4BAB75BA71

P698

Q42255433-29D102D4-35A7-45F4-B29B-2D2CFC5C7D48

P356

P1433

The Journal of Infectious Diseases

P1476

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

@en

P2093

Alexandra U Scherrer

http://www.w3.org/2001/XMLSchema#string

Beda Joos

http://www.w3.org/2001/XMLSchema#string

Benjamin Preiswerk

http://www.w3.org/2001/XMLSchema#string

Christina Grube

http://www.w3.org/2001/XMLSchema#string

Christine Leemann

http://www.w3.org/2001/XMLSchema#string

Dominique Braun

http://www.w3.org/2001/XMLSchema#string

Philip Rieder

http://www.w3.org/2001/XMLSchema#string

Pietro L Vernazza

http://www.w3.org/2001/XMLSchema#string

Rainer Weber

http://www.w3.org/2001/XMLSchema#string

Vincent Aubert

http://www.w3.org/2001/XMLSchema#string

P2860

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

Profile hidden Markov models

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

Emergence of primary NNRTI resistance mutations without antiretroviral selective pressure in a HAART-treated child

Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection

HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Minority variants of drug-resistant HIV.

Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection.

P304

1102-1112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIT310

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

208

http://www.w3.org/2001/XMLSchema#string

P50

Hansjakob Furrer

Enos Bernasconi

Alexandra Calmy

Swiss HIV Cohort Study

Huldrych F Günthard

Karin J Metzner

Matthias Cavassini

P577

2013-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260337914

http://www.w3.org/2001/XMLSchema#string

P698

23847055

http://www.w3.org/2001/XMLSchema#string